Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting

Abstract

Results demonstrate that HPMA copolymer-DOX conjugates are very promising and clinically suitable candidates for anticancer therapy.

Keywords

• HPMA copolymers
• drug carriers
• doxorubicin
• graft polymers
• EPR effect
• antitumor activity